2026 Minnesota Statutes

342.63 LABELING.

Subdivision 1.General.

All cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products sold to customers or patients must be labeled as required by this section and rules adopted under this chapter.

Subd. 2.Content of label; cannabis.

All cannabis flower and hemp-derived consumer products that consist of hemp plant parts sold to customers or patients must have affixed on the packaging or container of the cannabis flower or hemp-derived consumer product a label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis macrobusiness, or industrial hemp grower where the cannabis flower or hemp plant part was cultivated;

(2) the net weight of cannabis flower or hemp plant parts in the package or container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to section 342.61 and that the cannabis flower or hemp plant part complies with the applicable standards;

(7) the type of product, including directions on usage;

(8) the warning symbol established by the office indicating that the product is not for children and information about the Minnesota Poison Control Center; and

(9) any other statements or information required by the office.

Subd. 3.Content of label; cannabinoid products excluding lower-potency hemp edibles.

(a) All cannabis products, hemp concentrate, hemp-derived consumer products other than products subject to the requirements under subdivision 2, and medical cannabinoid products sold to customers or patients must have affixed to the packaging or container of the product a label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, lower-potency hemp edible manufacturer, cannabis macrobusiness, or industrial hemp grower that manufactured the cannabis concentrate, hemp concentrate, or artificially derived cannabinoid and, if different, the name and license number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, lower-potency hemp edible manufacturer, or cannabis macrobusiness that manufactured the product;

(2) the net weight of the product in the package or container;

(3) the type of product, including directions on usage;

(4) the batch number;

(5) the serving size;

(6) the cannabinoid profile per serving and in total;

(7) a list of ingredients;

(8) a universal symbol established by the office indicating that the package or container contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer product;

(9) a warning symbol established by the office indicating that the product is not for children and information about the Minnesota Poison Control Center;

(10) verification that the product was tested according to section 342.61; and

(11) any other statements or information required by the office.

(b) A ratio hemp-infused cannabis product as defined in section 342.01, subdivision 63a, must include on the label the following statement: "This product contains nonintoxicating cannabinoids derived from hemp."

Subd. 4.Additional content of label; medical cannabis flower and medical cannabinoid products.

In addition to the applicable requirements for labeling under subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must include at least the following information on the label affixed to the packaging or container of the medical cannabis flower or medical cannabinoid product:

(1) the patient's name and date of birth;

(2) if applicable, the name and date of birth of the patient's registered designated caregiver or, if listed on the registry verification, the name of the patient's parent, legal guardian, or spouse; and

(3) the patient's registry identification number.

Subd. 5.Content of label; hemp-derived topical products.

(a) All hemp-derived topical products sold to customers must have affixed to the packaging or container of the product a label that includes at least the following information:

(1) the manufacturer name, location, phone number, and website;

(2) the name and address of the independent, accredited laboratory used by the manufacturer to test the product;

(3) the net weight or volume of the product in the package or container;

(4) the type of topical product;

(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, derivative, or extract of hemp, per serving and in total;

(6) a list of ingredients;

(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any disease and that the product has not been evaluated or approved by the United States Food and Drug Administration, unless the product has been so approved; and

(8) any other statements or information required by the office.

(b) All hemp-derived topical products that contain THC must have affixed to the product's packaging or container a label that includes at least the following information:

(1) the information required in paragraph (a);

(2) the amount or percentage of THC per serving and the total THC;

(3) the universal symbol established by the office indicating that the package or container contains a product containing THC;

(4) the warning symbol established by the office indicating that the product is not for children and information about the Minnesota Poison Control Center; and

(5) information that the product was tested according to section 342.61, subdivision 4.

Subd. 6.Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or cannabis macrobusiness must provide customers and patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy machinery while under the influence of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for customers to report and obtain advice about side effects and adverse effects of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or cannabis macrobusiness may include the information described in paragraph (a) by:

(1) including the information on the label affixed to the packaging or container of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products;

(2) posting the information in the premises of the cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or cannabis macrobusiness; or

(3) providing the information on a separate document or pamphlet provided to customers or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer product.

Subd. 7.Labeling of lower-potency hemp edibles.

(a) All lower-potency hemp edible products must have affixed to the packaging or container a label that includes at least the following information:

(1) information about the business that cultivated the hemp parts used in the product, including either:

(i) the business's name, the business's address, and the country and state, if applicable, where the business operates; or

(ii) the business's name and business's license number;

(2) information about the business that manufactured the hemp concentrate and artificially derived cannabinoids used in the product, including either:

(i) the business's name, the business's address, and the country and state, if applicable, where the business operates; or

(ii) the business's name and the business's license number;

(3) the net weight of the lower-potency hemp edible product in the package or container;

(4) the batch number;

(5) the serving size;

(6) the cannabinoid profile per serving and total THC;

(7) a list of ingredients;

(8) the universal symbol established by the office indicating that the package or container contains a product containing THC;

(9) the warning symbol established by the office indicating that the product is not for children and information about the Minnesota Poison Control Center;

(10) verification that the lower-potency hemp edible was tested according to section 342.61;

(11) directions on the usage of the product; and

(12) any other statements or information required by the office.

(b) A cannabis or hemp business selling lower-potency hemp edibles to customers may provide customers with the required information in paragraph (a), clauses (1) and (2), through the use of a scannable barcode affixed to the label of the product if the barcode is accurate and active at all times.

(c) The label of a lower-potency hemp edible product that contains only nonintoxicating cannabinoids approved by the office and that does not include THC is not required to include the universal symbol in paragraph (a), clause (8).

History:

2023 c 63 art 1 s 64; 2024 c 121 art 2 s 128-130; 2025 c 31 s 98-101; 2026 c 123 s 108-113